InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by 김영선, Directeur. Insider active across 2 companies, notably 동국생명과학. Cumulatively, 2 filings have been logged. History available since 8 April 2026. The latest transaction was filed on 8 April 2026 (Purchase). Regulator: DART (FSS). The full history is free.
2 of 2 declarations
Kim Young-sun is an Executive Director at Dongguk Life Science, a company active in the life sciences field. In this role, he oversees operations and contributes to product development strategy. Kim Young-sun is recognized for his expertise in the sector and for his ability to lead teams toward innovation. His commitment to quality and efficiency is essential for Dongguk Life Science's success.